Overview

Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the Pharmacokinetics and Pharmacodynamics of alogliptin after a single or multiple administrations, once daily (QD), of oral alogliptin in healthy Korean subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Alogliptin